218 related articles for article (PubMed ID: 18814214)
1. Inhibition of cytochrome P450 enzymes by rhein in rat liver microsomes.
Tang JC; Yang H; Song XY; Song XH; Yan SL; Shao JQ; Zhang TL; Zhang JN
Phytother Res; 2009 Feb; 23(2):159-64. PubMed ID: 18814214
[TBL] [Abstract][Full Text] [Related]
2. Effect of acetylcholinesterase oxime-type reactivators K-48 and HI-6 on human liver microsomal cytochromes P450 in vitro.
Veinlichova A; Jancova P; Siller M; Anzenbacher P; Kuca K; Jun D; Fusek J; Anzenbacherova E
Chem Biol Interact; 2009 Aug; 180(3):449-53. PubMed ID: 19539805
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of cytostatically active 6-aminobenzo[c]phenanthridines on cytochrome P450 enzymes in human hepatic microsomes.
Zebothsen I; Kunze T; Clement B
Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):37-43. PubMed ID: 16867169
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human cytochrome P450 isoforms and NADPH-CYP reductase in vitro by 15 herbal medicines, including Epimedii herba.
Liu KH; Kim MJ; Jeon BH; Shon JH; Cha IJ; Cho KH; Lee SS; Shin JG
J Clin Pharm Ther; 2006 Feb; 31(1):83-91. PubMed ID: 16476124
[TBL] [Abstract][Full Text] [Related]
5. Differential inhibition of rat and human hepatic cytochrome P450 by Andrographis paniculata extract and andrographolide.
Pekthong D; Martin H; Abadie C; Bonet A; Heyd B; Mantion G; Richert L
J Ethnopharmacol; 2008 Feb; 115(3):432-40. PubMed ID: 18053665
[TBL] [Abstract][Full Text] [Related]
6. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes.
Yao HT; Chang YW; Lan SJ; Yeh TK
Food Chem Toxicol; 2008 Feb; 46(2):645-53. PubMed ID: 17950511
[TBL] [Abstract][Full Text] [Related]
7. Influence of classic and atypical neuroleptics on caffeine oxidation in rat liver microsomes.
Daniel WA; Kot M; Wójcikowski J
Pol J Pharmacol; 2003; 55(6):1055-61. PubMed ID: 14730101
[TBL] [Abstract][Full Text] [Related]
8. Inhibitive effect of diphenytriazol on rat cytochrome P450 enzyme in vitro.
Hu YZ; Yao TW
Pharmazie; 2009 Jul; 64(7):455-60. PubMed ID: 19694183
[TBL] [Abstract][Full Text] [Related]
9. An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents.
Etheridge AS; Black SR; Patel PR; So J; Mathews JM
Planta Med; 2007 Jul; 73(8):731-41. PubMed ID: 17611934
[TBL] [Abstract][Full Text] [Related]
10. Investigation of drug-drug interaction potential of bortezomib in vivo in female Sprague-Dawley rats and in vitro in human liver microsomes.
Lu C; Gallegos R; Li P; Xia CQ; Pusalkar S; Uttamsingh V; Nix D; Miwa GT; Gan LS
Drug Metab Dispos; 2006 Apr; 34(4):702-8. PubMed ID: 16443666
[TBL] [Abstract][Full Text] [Related]
11. The novel antifungal agent PLD-118 is neither metabolized by liver microsomes nor inhibits cytochrome P450 in vitro.
Parnham MJ; Bogaards JJ; Schrander F; Schut MW; Oresković K; Mildner B
Biopharm Drug Dispos; 2005 Jan; 26(1):27-33. PubMed ID: 15593345
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the cytochrome P450 enzymes and enzyme kinetic parameters for metabolism of BVT.2938 using different in vitro systems.
Baranczewski P; Edlund PO; Postlind H
J Pharm Biomed Anal; 2006 Mar; 40(5):1121-30. PubMed ID: 16307862
[TBL] [Abstract][Full Text] [Related]
13. Reversible inhibition of four important human liver cytochrome P450 enzymes by diethylstilbestrol.
Qu YQ; Fang ZZ; Yang L; Gao ZM; Liang R; Zhu LL; Dong PP; Zhang YY; Ge GB; Wang LM
Pharmazie; 2011 Mar; 66(3):216-21. PubMed ID: 21553654
[TBL] [Abstract][Full Text] [Related]
14. Metabolism and transporter-mediated drug-drug interactions of the endothelin-A receptor antagonist CI-1034.
Sahi J; Sinz MW; Campbell S; Mireles R; Zheng X; Rose KA; Raeissi S; Hashim MF; Ye Y; de Morais SM; Black C; Tugnait M; Keller LH
Chem Biol Interact; 2006 Feb; 159(2):156-68. PubMed ID: 16356485
[TBL] [Abstract][Full Text] [Related]
15. Anthraquinones inhibit cytochromes P450 enzyme activity in silico and in vitro.
Liu Y; Mapa MST; Sprando RL
J Appl Toxicol; 2021 Sep; 41(9):1438-1445. PubMed ID: 33438235
[TBL] [Abstract][Full Text] [Related]
16. Application of higher throughput screening (HTS) inhibition assays to evaluate the interaction of antiparasitic drugs with cytochrome P450s.
Bapiro TE; Egnell AC; Hasler JA; Masimirembwa CM
Drug Metab Dispos; 2001 Jan; 29(1):30-5. PubMed ID: 11124226
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human liver microsomal cytochrome P450 activities by adefovir and tenofovir.
Nekvindová J; Masek V; Veinlichová A; Anzenbacherová E; Anzenbacher P; Zídek Z; Holý A
Xenobiotica; 2006 Dec; 36(12):1165-77. PubMed ID: 17162464
[TBL] [Abstract][Full Text] [Related]
18. Human cytochrome p450 induction and inhibition potential of clevidipine and its primary metabolite h152/81.
Zhang JG; Dehal SS; Ho T; Johnson J; Chandler C; Blanchard AP; Clark RJ; Crespi CL; Stresser DM; Wong J
Drug Metab Dispos; 2006 May; 34(5):734-7. PubMed ID: 16501008
[TBL] [Abstract][Full Text] [Related]
19. 2-Diethylaminoethyl-2,2-diphenylvalerate-HCl (SKF525A) revisited: comparative cytochrome P450 inhibition in human liver microsomes by SKF525A, its metabolites, and SKF-acid and SKF-alcohol.
Franklin MR; Hathaway LB
Drug Metab Dispos; 2008 Dec; 36(12):2539-46. PubMed ID: 18799803
[TBL] [Abstract][Full Text] [Related]
20. Cocktail-substrate assay system for mechanism-based inhibition of CYP2C9, CYP2D6, and CYP3A using human liver microsomes at an early stage of drug development.
Mori K; Hashimoto H; Takatsu H; Tsuda-Tsukimoto M; Kume T
Xenobiotica; 2009 Jun; 39(6):415-22. PubMed ID: 19480547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
